⌕
Elanco Animal Health · ELAN · NYSE
Tenet 37 · Weak
Compare
$25.85−2.12%At closeTenet 37 · Weak
$25.85−0.56 (−2.12%)
At close: Nov 17, 2026, 4:00 PM ET· NYSE · USD

Elanco Animal Health (ELAN) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~−0.3%/yr (FY21→FY25), net margin −4.9%. Worth your attention in FY25: Capex step-up ($276.0M). Visible in the receipts below.
The four lines that matter · FY21–FY25
Revenue ($M)▲6.2%
4,715.0
FY21→FY25CAGR −0.3%/yr
Net income ($M)—
−232.0
one-off year: see footnoteCAGR —
Free cash flow ($M)▼27.9%
284.0
capex stepped upCAGR −3.2%/yr
Diluted EPS—
−0.47
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+1.9%

487.2mn → 496.4mn diluted shares since FY21. Broadly flat, so EPS moves with net income rather than with the share count.

Capex step-up
$276.0M

▲88% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)4715.0Revenue−2122.0COGS2593.0Gross profit−368.0R&D−1430.0SG&A−4.0Op income−228.0Tax & other−232.0Net income

-5¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.

Margin trend · direction beats level Gross Operating Net
604530150%sector median net margin ~3%FY21FY25

Over this window: gross 55.2% → 55.0%. Net margin -4.9% is below the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
5,148.04,715.04,439.04,417.04,411.04,764.0▲6.2%−0.3%
Cost of revenue
2,256.02,122.02,003.01,931.01,913.02,132.0▲5.9%−0.1%
Gross profit
2,892.02,593.02,436.02,486.02,498.02,632.0▲6.4%−0.4%
Research & development
381.0368.0344.0327.0321.0369.0▲7.0%−0.1%
Selling, general & admin
1,561.01,430.01,314.01,285.01,265.01,403.0▲8.8%+0.5%
Total operating expenses
2,752.02,597.02,353.03,404.02,329.02,967.0▲10.4%−3.3%
Operating incomefeeds ROC rank
140.0−4.083.0−918.0169.0−335.0——
Other income, net
−232.0−220.0405.0−277.0−241.0−236.0——
Pretax income
−92.0−224.0488.0−1,195.0−72.0−571.0——
Income tax
55.08.0150.036.06.0−88.0▼94.7%+10.1% (22→25)
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−147.0−232.0338.0−1,231.0−78.0−483.0——
Per share
Diluted EPSbuyback-sensitive
−0.29−0.470.68−2.50−0.16−0.99——
Diluted shares (mn)
506.50496.40497.30492.30488.30487.20▼0.2%+0.5%
Margins
Gross margin37th pct in Healthcare
56.2%55.0%54.9%56.3%56.6%55.2%▲0.1pp−0.3pp
Operating margin
2.7%−0.1%1.9%−20.8%3.8%−7.0%▼2.0pp+6.9pp
Net margin34th pct in Healthcare
−2.9%−4.9%7.6%−27.9%−1.8%−10.1%▼12.5pp+5.2pp
† TTM = trailing four quarters through 2026-09-30.FY21 effective tax rate was 15% vs a −3% norm for this window, likely a one-time item; see the filing.FY24 effective tax rate was 31% vs a −3% norm for this window, likely a one-time item; see the filing.
FY16 – FY20 · 5 more years
Unlock the full history →
5 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-24 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was Elanco Animal Health's revenue last fiscal year?

Elanco Animal Health reported revenue of $4,715.0M in fiscal 2025, up 6.2% from fiscal 2024.

What was Elanco Animal Health's net income?

Elanco Animal Health reported net income of −$232.0M in fiscal 2025, a net margin of −4.9%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.